华夏国药

华夏国药（菏泽）制药有限公司, formerly known as Shandong Baiwei Pharmaceutical Co., Ltd., is a comprehensive modern pharmaceutical company specializing in the research, development, production, and commercialization of both chemical drugs and traditional Chinese medicines (TCM). Headquartered in Heze, Shandong Province, China, the company operates advanced manufacturing facilities capable of producing six major dosage forms, including tablets, capsules, soft capsules, granules, powders, and active pharmaceutical ingredients (APIs). Its commercial portfolio features widely distributed products such as Vitamin D3 drops, Vitamin C effervescent tablets, Lactasin tablets, and Shenqi Wuweizi capsules. To drive long-term growth, the company actively expands its pipeline by conducting bioequivalence studies and submitting regulatory applications for key generic small molecules, including butylphthalide soft capsules for stroke and menatetrenone soft capsules for osteoporosis.